# Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)

> **NCT03278509** · PHASE4 · UNKNOWN · sponsor: **Karolinska Institutet** · enrollment: 5000 (estimated)

## Conditions studied

- Acute Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Metoprolol Succinate
- **DRUG:** Bisoprolol

## Key facts

- **NCT ID:** NCT03278509
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-11
- **Primary completion:** 2023-11-16
- **Final completion:** 2025-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03278509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03278509, "Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03278509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*